መነሻ › አቶፒክ ደርማቲቲስ (ኤክዜማ) › ሜሪላንድ
በሜሪላንድ ለአቶፒክ ደርማቲቲስ (ኤክዜማ) የሚደረጉ ክሊኒካዊ ጥናቶች
ለአቶፒክ ደርማቲቲስ (ኤክዜማ) የሚደረጉ 16 ጥናቶች በሜሪላንድ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በሜሪላንድ ውስጥ ያሉ ከተሞች
Official study text (English)
Natural History and Genetics of Food Allergy and Related Conditions
- National Institutes of Health Clinical Center, Bethesda
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
1 Day – 99 Years · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT02504853Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
- National Institutes of Health Clinical Center, Bethesda
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ12 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07262983Effects of Treatments on Atopic Dermatitis
- National Institutes of Health Clinical Center, Bethesda
ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ2 እስከ 50 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT01631617A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Rockville
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07003425Metabolic Profiling of Immune Responses in Immune-mediated Diseases
- National Institutes of Health Clinical Center, Bethesda
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT04864886Studies of Skin Microbes in Healthy People and in People With Skin Conditions
- National Institutes of Health Clinical Center, Bethesda
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ2 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT00605878Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- U.S. Dermatology Partners Rockville, Rockville
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ12 እስከ 89 · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT07645820A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Chesapeake Clinical Research, Inc, Pasadena
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT07599813Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
- National Institutes of Health Clinical Center, Bethesda
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ3 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT03835767Cardamom and Topical Roseomonas in Atopic Dermatitis
- National Institutes of Health Clinical Center, Bethesda
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ2 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ13 ኦገስ 2026 · NCT06096857A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Maryland Allergy & Asthma Center /ID# 268032, Lanham
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 11 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT06461897A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
- National Institutes of Health Clinical Center, Bethesda
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ3 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ17 ጁላይ 2026 · NCT06732414A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Maryland Laser Skin and Vein, Hunt Valley
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሜይ 2026 · NCT05995964Dupilumab De-escalation in Pediatric Atopic Dermatitis
- Johns Hopkins Univerisity, Baltimore
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ1 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ20 ኤፕሪ 2026 · NCT06116526Registry for Systemic Eczema Treatments
- Johns Hopkins University, Baltimore
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ1 እስከ 26 · ሁሉም ጾታዎች · የተሻሻለው በ7 ኤፕሪ 2026 · NCT06136767Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7098, Columbia
- Galderma Investigational Site 8012, Glenn Dale
- Galderma Investigational Site 7068, Rockville
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ማርች 2026 · NCT06988605ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።